Newsroom Careers Contact Us

Knowing Novugen

Novugen is a global pharmaceutical company specializing in complex, and highly technical generics for all therapeutic areas of oncology and general medicine while meeting strict global quality standards. Highly driven to challenge the status quo, Novugen is committed to provide early access of affordable medicine with the highest quality to the world.


Capabilities to Develop and Manufacture Wide Range of Dosage Forms

Novugen develops, manufactures, and distributes products that are latest in the line of treatment while meeting strict global quality standards.

Research & Development

Based in Malaysia, our global R&D centre spreads across 40,000 sq.ft facility

We continuously invest in our R&D to support technology-intensive generic products. Today, the people behind our R&D consists of over 200 experienced scientists.

Research & Development

Building Our
Strength Through

We continuously seek to grow our product lines through strategic partnership globally. Aligned with our strategy to expand worldwide, we leverage on carefully selected collaborations that enhances our long track record of innovation and creative capabilities.


We are passionate to make a difference in the lives of others

Be part of our passionate team in making an impact to patients’ lives around the world and take your next career step with our company.


News And Company Insights

Explore latest news about us from across the globe.

Novugen in U.S. Drugstore Management Magazine
ANDA Approval for Sunitinib
Novugen in Caring News, Jul – Sep 2023 Issue
NACDS Total Store Expo 2023 San Diego, California, U.S.A.
NPRA Approval for Novugen Products
MIDA MITI Day 2023
Industry Visit by Biomedical Science Students from City University Malaysia
Human Resources Online Suite Talk by Rahil Mahmood
Official Launch of Oncogen Pharma Pakistan
National Heart Association of Malaysia (NHAM) Congress 2023
Launch of Novtor Rosuvastatin
Novugen's First Halal Certified Products
Launch of Dapiga
Novugen's 8-year Anniversary
Announcement of Company Name Change
Novugen 1st International Cardiometabolic and Urogynecology Summit (NICUS)
Official Product Launch and Distribution Partner Zuellig Pharma
Novugen Oncology Received the First ANDA Approval for Abiraterone 250mg and 500mg Tablets
Novugen Welcomes Deputy Chief Executive Officer of MIDA
Pioneering Novugen Pharma Vision in North America
Malaysia Thailand Collaboration to Increase the Affordability and Accessibility of Cancer Drugs in Thailand
Novugen Oncology Becoming the Largest and Fastest Growing Pharmaceutical Company in ASEAN by 2025
Novugen Oncology & Brightgene Bio-Medical Technology Announce Strategic Partnership to Enter U.S.A Pharma Market
Visit by The Deputy Minister of International Trade and Industry (MITI) and The Deputy Chief Executive Officer II of MIDA
Novugen Oncology Launches ASEAN’s First Oncology API R&D Centre

We are passionate for science and dedicated to change lives

Learn more about Novugen and our journey in supporting the medical needs of patients globally.